Cardiology

Top Story

Novel DCB may improve outcomes in patients with femoropopliteal artery lesions

April 25, 2017

Patients with femoropopliteal artery lesions who were treated by angioplasty with a drug-coated balloon showed improved symptoms and freedom from target lesion revascularization compared with those with uncoated balloons, according to results presented at the Charing Cross Symposium.

Researchers analyzed 105 patients with femoropopliteal artery lesions from 10 sites in Europe who were assigned percutaneous transluminal angioplasty with the paclitaxel-coated balloon (Ranger, Boston Scientific; n = 71; mean age, 68 years; 75% men) or an uncoated balloon (n = 34; mean age, 67 years; 68% men).

In the Journals

Kidney disease plays major role in cardiovascular deaths

April 25, 2017
By 2013, cardiovascular deaths attributed to reduced kidney function outnumbered kidney failure deaths globally, suggesting that early detection and treatment of chronic…
In the Journals

Bivalirudin linked to reduced bleeding in patients with STEMI undergoing PCI

April 25, 2017
Compared with heparin or heparin combined with glycoprotein IIb/IIIa inhibitors, bivalirudin treatment was associated with reduced adverse clinical events in patients…
In the Journals

USPSTF recommends routine BP measurements for preeclampsia screening

April 25, 2017
The U.S. Preventive Services Task Force recommended routine BP measurements to screen for preeclampsia in women throughout pregnancy, according to a statement published…
FDA News

New monthly dose of alirocumab granted approval

April 25, 2017
The FDA has approved a 300-mg once-monthly dose of alirocumab for injection, Regeneron and Sanofi announced. The approval of the new dose is based on results from phase…
More News Headlines »
Advertisement
Advertisement